greeksoup/ stock research

Resmed (RMD) FY2023 results: revenue $4.2 billion, up 18.0% on the year

Resmed Inc. (RMD) reported revenue of $4.2 billion for fiscal 2023, the year ended 30 June 2023, up 18.0% on the year before. Net income was $898 million, up 15.2%, and diluted earnings per share $6.09. The figures are the company's own, from the 10-K it filed with the SEC on 11 August 2023.

Revenue
$4.2 billion
+18.0% on the year
FY2016FY2023
Operating margin
26.8%
28.0% a year earlier
FY2016FY2023
Net income
$898 million
+15.2% on the year
FY2016FY2023
Diluted EPS
$6.09
+14.9% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue4,2233,5783,197+18.0%
Cost of revenue1,8671,5541,358+20.2%
Gross profit2,3562,0241,839+16.4%
Gross margin55.8%56.6%57.5%
Research and development288254225+13.4%
Selling, general and administrative874738670+18.5%
Operating income1,1321,000904+13.2%
Operating margin26.8%28.0%28.3%
Interest expensen/an/a24.0
Pre-tax income1,102960884+14.7%
Income tax204181409+12.7%
Effective tax rate18.5%18.8%46.3%
Net income898779475+15.2%
Net margin21.3%21.8%14.8%
Diluted EPS$6.09$5.30$3.24+14.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow693351737+97.4%
Capital expenditure120135103-11.2%
Free cash flow574216634+165.2%
Free cash flow margin13.6%6.0%19.8%
Cash from investing-1,160-230-158
Cash from financing423-128-765
Depreciation and amortisation165160157+3.5%
Share-based compensation71.165.363.9+9.0%
Buybacks0.00.0n/a
Dividends paid258245227+5.3%
Dividend per share$1.76$1.68$1.56+4.8%
Diluted shares, weighted147m147m146m+0.3%
Shares outstanding at period end147m146m146m+0.4%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity4,1303,3612,886+22.9%
Debt1,441775655+85.9%
Operating lease liabilities117120115-3.0%
Other liabilities1,0648391,072+26.7%
Total liabilities and equity6,7525,0964,728+32.5%
Fixed assets538498463+8.0%
Goodwill2,7701,9361,928+43.1%
Intangible assets552346393+59.7%
Cash and equivalents228274295-16.7%
Receivables705576614+22.4%
Inventory998744457+34.2%
Other assets960722578+33.1%
Total assets6,7525,0964,728+32.5%

10-K for the year ended 30 June 2023, filed 11 August 2023: the filing.